Oxford Science Enterprises

Oxford Science Enterprises (OSE) was founded in 2015 with a £320m initial commitment from the University of Oxford and a consortium of institutional backers including Sequoia Capital, and now manages over £1bn. It holds co-investment rights on University of Oxford spinouts, giving it first-look access to technology commercialised through the university's technology transfer office, and operates a permanent capital model that reinvests returns to maintain its position across Oxford's deeptech pipeline.

Its portfolio includes Oxford Nanopore Technologies, now FTSE-listed, and Exscientia, listed on Nasdaq, alongside a run of Quantum computing, materials Science and AI hardware companies still in formation. OSE's continued participation in Fractile's funding rounds, including its $220m Series B in May 2026 alongside NATO's Innovation Fund and the CIA's In-Q-Tel, illustrates how the fund maintains position through successive rounds rather than exiting early.

The fund's structure, embedded deal-flow access plus permanent capital, is the main mechanism keeping commercial value from Oxford's research base inside a UK-anchored vehicle, even as allied state investors increasingly compete for stakes in the same generation of university spinouts.